Harmony Biosciences Holdings Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Harmony Biosciences Holdings Inc had 589.40M in cash and cash equivalents.

Harmony Biosciences Holdings Inc reported 401.41M in total liabilities as of the latest reported quarter, including 252.13M in current liabilities and 149.28M in non-current liabilities.

As of the latest reported quarter, Harmony Biosciences Holdings Inc's total assets were 1.27B, consisting of 907.01M in current assets and 364.62M in non-current assets.

Harmony Biosciences Holdings Inc reported 870.22M in total shareholders' equity as of the latest reported quarter.